This inventor holds 1 USPTO granted patent. Top assignees: Merck + Co., Inc., Merck Frosst Canada, Inc.. Active years: 1993.
Company Filing History:
1 out of 4,770 
1 out of 212 
Years Active: 1993
Title: Yvan Guinon: Innovator in Leukotriene Research
Introduction
Yvan Guinon is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biochemistry, particularly in the study of leukotrienes. His work has implications for understanding various physiological processes and potential therapeutic targets.
Latest Patents
Yvan Guinon holds a patent for the 5-lipoxygenase activating protein (FLAP). This 18kD protein has been isolated from rat and human cells and is essential for the production of leukotrienes from arachidonic acid in mammalian cells containing 5-lipoxygenase. The gene (cDNA) encoding for FLAP has also been produced, showcasing his innovative approach to biochemistry.
Career Highlights
Throughout his career, Yvan has worked with prominent companies such as Merck Frosst Canada, Inc. and Merck & Co., Inc. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.
Collaborations
Yvan has collaborated with esteemed colleagues, including John W. Gillard and Jillian F. Evans. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Yvan Guinon's contributions to the field of leukotriene research and his innovative patent for FLAP highlight his importance as an inventor. His work continues to influence the understanding of biochemical processes and potential therapeutic applications.